Bispecific antibody therapeutics represent a transformativeapproach to modern treatment; over the years, this upcoming class of ‘two-target’artificially engineered drugs have generated significant enthusiasm within themedical science community
Roots Analysis is pleased to announce the publication of its recentstudy, titled, “Bispecific Antibody Therapeutics Market (4thEdition), 2020-2030.”
Formore Insightful information please click on link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
The report features an extensive study of the currentmarket landscape, offering an informed opinion on the likely adoption of thesetherapeutics over the next decade. The study features an in-depth analysis,highlighting the capabilities of various stakeholders engaged in this domain.Amongst other elements, the report includes:
§ Adetailed assessment of the current market landscape of drug developers engagedin the development of bispecific antibody therapeutics.
§ Acomprehensive analysis of novel technology platforms that are eithercurrently available or being developed for the generation of bispecificantibody therapeutics.
§ Detailedprofiles of marketed and clinical stage (phase II and phase III) bispecificantibody therapeutics.
§ Keytakeaways from the bispecific antibody therapeutics pipeline.
§ Ananalysis of the initiatives of big biopharma players engaged in this domain.
§ Ananalysis of recent partnerships and collaboration agreements inked in bispecificantibody therapeutics domain.
§ Areview on the key steps involved and challenges associated with themanufacturing of bispecific antibodies.
§ Aclinical trial analysis of ongoing and planned studies related to bispecificantibody therapeutics.
§ Areview of the key promotional strategies that have been adopted by thedevelopers of the marketed bispecific antibodies.
§ Adiscussion on important, industry-specific trends, key market drivers andchallenges, under a SWOT framework.
§ A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)
- Target Disease Indication
§ AutoimmuneDisorders
§ EyeDisorders
§ GeneticDisorders
§ HematologicalMalignancies
§ InfectiousDiseases
§ InflammatoryDisorders
§ SkinDisorders
- Mechanism of Action
§ CytokinesRetargeting / Neutralization
§ DualLigands Blocking
§ T-cellRetargeting / Activation
§ Others
To request a samplereport - https://www.rootsanalysis.com/reports/286/request-sample.html
- Target Antigens
§ CD3x CD19
§ CD30x CD16A
§ FactorIXa x Factor X
§ IL-1αx IL-1β
§ IL-13x IL-4
§ IL-17Ax Albumin
§ IL-17Ax IL-17F
§ Pslx PcrV
§ TNF-αx HAS
§ VEGF-Ax ANG2
§ Others
- Antibody Format
§ Asymmetric
§ Fragments
§ Symmetric
§ Others
- Key Geographical Region
§ NorthAmerica
§ Europe
§ Asia-Pacific
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies:
§ Martin Steiner (Chief Executive Officer, Synimmune)
§ Ludger Große-Hovest (Chief Scientific Officer, Synimmune)
§ Jane Dancer (Chief Business Officer, F-Star)
§ Siobhan Pomeroy (Senior Director, Business Development, CytomX)
§ Yinjue Wang (Associate Director, Process Development,Innovent Biologics)
To request a customize report – https://www.rootsanalysis.com/reports/bispecific-antibodies/request-customization.html
Keycompanies covered in the report
§ Amgen
§ Ablynx
§ AbbVie
§ Affibody
§ Affimed
§ Alphamab
§ AstraZeneca
§ Avillion
§ Chugai Pharmaceuticals
§ Eddingpharm
§ GSK
§ Merck
§ Merus
§ Roche
§ Regeneron Pharmaceuticals
§ Taisho Pharmaceuticals
§ Zymeworks
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Other Recent Offerings
1. Global Preventive Vaccines Market,2020-2030
2. Endocannabinoid System TargetedTherapeuticsMarket, 2019-2030
3. Antibody Contract Manufacturing Market, 2020-2030
4. Cloud-based Solutionsfor Drug Discovery, Development and Manufacturing Market
6. Alpha-1 AntitrypsinDeficiency (AATD)
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
